Skip to main content
PTC seeks EMA's approval for AADC gene therapy candidate
1/17/2020

A marketing authorization application was filed by PTC Therapeutics with the European Medicines Agency seeking the agency's approval for its gene therapy candidate PTC-AADC as a treatment for aromatic l-amino acid decarboxylase deficiency.

Full Story: